Brainsway Ltd. BWAY
Annual
Quarterly
FY2024 · ended Dec 31, 2024 · Revenue $41.02M, +29.0% YoY · Filed Apr 22, 2025
Brainsway Ltd. (BWAY) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2024, which ended Dec 31, 2024, it reported revenue of $41.0 million and net income of $2.9 million. As of Dec 31, 2024 it held $69.3 million in cash and investments and $5.6 million in total debt.
Revenue
$41.02M
+29.0% vs prior year
Net income
$2.92M
+169.6% vs prior year
Operating cash flow
$10.30M
+702.0% vs prior year
Free cash flow
$-1.35M
+65.3% vs prior year
EPS
$0.05
+138.5% vs prior year
Dividend per share
None
Shares outstanding
39.17M
+4.1% vs prior year
Net cash
$63.72M
FY 2024
Operating margin
3.4%
FY 2024
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BWAY (Nasdaq), BRSYF (OTC)
- Incorporated in
- Israel
- Headquarters
- Jerusalem, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1505065
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $41.0M | $31.8M | $27.2M | $29.7M | $22.1M |
| Operating income | $1.4M | -$5.0M | -$12.7M | -$5.0M | -$4.8M |
| Net income | $2.9M | -$4.2M | -$13.3M | -$6.5M | -$5.4M |
| Diluted EPS | $0.05 | -$0.13 | — | — | — |
| Operating cash flow | $10.3M | $1.3M | -$9.8M | $884,000 | -$1.4M |
| Free cash flow | — | — | — | -$1.4M | -$3.9M |
| Total assets | $94.3M | $63.0M | $64.5M | $75.7M | $34.0M |
| Stockholders' equity | $62.3M | $41.6M | $45.4M | $57.3M | $19.6M |
| Cash and investments | $69.3M | $10.5M | $47.6M | $16.9M | $17.0M |
| Total debt | $5.6M | $471,000 | $488,000 | $754,000 | $672,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Nov 2, 2026 |
| 6-K/A | Form 6-k/a | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Nov 25, 2026 |
| 6-K | Current report (foreign issuer) | Oct 19, 2026 | Oct 19, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
All 281 Brainsway Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.